Injective price prediction: Can selling pressure fade? INJ gains 7.15%

Traders Union
All News
Crypto News
Injective rises 7.15% to $4.51 today

Highlights

Injective (INJ) trades at $4.51, remaining below MA-20 ($4.74), MA-50 ($5.48), and MA-200 ($10.29), signaling persistent selling pressure across all timeframes.
Despite a 7.15% intraday rally from its $4.19 open to the session high of $4.51, momentum indicators including MACD and ADX continue to reflect a firm bearish trend.
With INJ projected to range between $4.18 and $4.95 over the next five days, the probability of further price increases is low, and a break below $4.18 could trigger renewed selling.

Bearish momentum persists as technical signals point to oversold conditions

Momentum signals remain skewed to the downside, with MACD on D1 at Strong Sell and ADX indicating a firm bearish trend. RSI and CCI both suggest oversold territory, but the Stochastic RSI shows a neutral print while BBP at –0.11 highlights ongoing seller dominance. The nearest dynamic resistance is the Ichimoku Kijun at $5.19, while MA-20 and the lower end of today’s range near $4.16 serve as support.

Downside risk heightened as bullish reversal faces strong resistance

Over the next five trading days, the expected price range is set between $4.18 and $4.95, reflecting the need to keep forecasts within a 10% volatility band relative to current levels. The probability of a further price increase is very low (less than 20%), making a downside move much more likely. The baseline scenario anticipates INJ stabilizing in a sideways corridor just above recent lows. A breakout above $5.19 would be required for buyers to gain traction again, while a move below $4.18 could prompt renewed selling pressure.

Anton Kharitonov, expert at Traders Union, sees clear technical weakness in INJ as selling pressure dominates all timeframes. He notes that momentum remains bearish, with oversold signals lacking confirmation and resistance levels proving firm. Kharitonov believes a further downside is likely unless $5.19 is reclaimed soon. "My base case is sideways or more weakness—until bulls reclaim $5.19, I remain defensive on INJ."

Previously it was reported that Injective is experiencing persistent bearish momentum, with the price trading well below all major moving averages and technical indicators such as MACD, ADX, and various oscillators confirming significant downside pressure and oversold conditions. Support is found near recent lows, while resistance remains at the Ichimoku Kijun level, with the asset likely to consolidate between $4.15 and $4.85 unless key resistance is reclaimed.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.